Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state

  • Authors:
    • Domenico Dell'Edera
    • Andrea Tinelli
    • Giusi Natalia Milazzo
    • Antonio Malvasi
    • Carone Domenico
    • Elena Pacella
    • Compagnoni Pierluigi
    • Tarantino Giuseppe
    • Guido Marcello
    • Lomurno Francesco
    • Annunziata Anna Epifania
  • View Affiliations

  • Published online on: June 28, 2013     https://doi.org/10.3892/mmr.2013.1563
  • Pages: 609-612
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The role of hyperhomocysteinemia (HHcy) as a cardiovascular risk factor remains a matter of debate, while it correlates with folates, it demonstrates inverse correlation with plasma homocysteine (Hcy) levels and vitamin B12 levels and reduces plasma Hcy levels following supplementation with multivitamins. The purpose of this study was to demonstrate that administering multivitamins at specific doses for 90 days restores normal plasma Hcy levels in women who are homozygous for the thermolabile variant of 5,10 methylenetetrahydrofolate reductase (MTHFR C677T). We enrolled 106 healthy females aged between 30 and 42 years, who were non-smokers, non-vegetarian, normotensive and who had no history of food abuse in the previous months. Only females were enrolled in order to rule out any bias due to the variation in Hcy plasma concentrations between males and females. Patient blood sampling was performed in order to determine plasma Hcy, serum folic acid and vitamin B12 levels. Furthermore, molecular characterization of the C677T polymorphism present in the MTHFR gene, was also performed. The results of this study demonstrated that supplementation with specific multivitamins restores normal plasma Hcy levels, regardless of the MTHFR genotype. Furthermore, it is unnecessary to adminster high doses of folate to reduce plasma Hcy levels, and administering high doses of folate may cause pro-inflammatory and pro-proliferative effects.

References

1 

Shiraiwa T, Nakagawa K, Kanemoto N, Kinda T and Yamamoto H: Synthesis of optically active homocysteine from methionine and its use in preparing four stereoisomers of cystathionine. Chem Pharm Bull (Tokyo). 50:1081–1085. 2002. View Article : Google Scholar : PubMed/NCBI

2 

de Franchis R, Fermo I, Mazzola G, Sebastio G, Di Minno G, Coppola A, Andria G and D’Angelo A: Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia. Thromb Haemost. 84:576–582. 2000.PubMed/NCBI

3 

Mudd SH, Levy HL and Skovby F: Disorders of transsulfuration. The Metabolic and Molecular Bases of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B and Vogelstein B: McGraw Hill; NY: 88. pp. 2008–2048. 2001

4 

Hultberg B, Andersson A, Masson P, Larson M and Tunek A: Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest. 54:417–422. 1994. View Article : Google Scholar : PubMed/NCBI

5 

Aćimović JM, Stanimirović BD, Todorović N, Jovanović VB and Mandić LM: Influence of the microenvironment of thiol groups in low molecular mass thiols and serum albumin on the reaction with methylglyoxal. Chem Biol Interact. 188:21–30. 2010.PubMed/NCBI

6 

Moshal KS, Sen U, Tyagi N, Henderson B, Steed M, Ovechkin AV and Tyagi SC: Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol. 290:C883–C891. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Hultberg B: Elimination of high amounts of extracellular homocysteine in human cell lines. Clin Chim Acta. 356:117–124. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Humphrey LL, Fu R, Rogers K, Freeman M and Helfand M: Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 83:1203–1212. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J and Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:7–9. 1996. View Article : Google Scholar

10 

Guttormsen AB, Ueland PM, Nesthus I, Nygård O, Schneede J, Vollset SE and Refsum H: Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest. 98:2174–2183. 1996.PubMed/NCBI

11 

Smulders YM and Blom HJ: The homocysteine controversy. J Inherit Metab Dis. 34:93–99. 2011. View Article : Google Scholar

12 

Quéré I, Perneger TV, Zittoun J, et al: Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet. 359:747–752. 2002.PubMed/NCBI

Related Articles

Journal Cover

August 2013
Volume 8 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Dell'Edera, D., Tinelli, A., Milazzo, G.N., Malvasi, A., Domenico, C., Pacella, E. ... Epifania, A.A. (2013). Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state. Molecular Medicine Reports, 8, 609-612. https://doi.org/10.3892/mmr.2013.1563
MLA
Dell'Edera, D., Tinelli, A., Milazzo, G. N., Malvasi, A., Domenico, C., Pacella, E., Pierluigi, C., Giuseppe, T., Marcello, G., Francesco, L., Epifania, A. A."Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state". Molecular Medicine Reports 8.2 (2013): 609-612.
Chicago
Dell'Edera, D., Tinelli, A., Milazzo, G. N., Malvasi, A., Domenico, C., Pacella, E., Pierluigi, C., Giuseppe, T., Marcello, G., Francesco, L., Epifania, A. A."Effect of multivitamins on plasma homocysteine in patients with the 5,10 methylenetetrahydrofolate reductase C677T homozygous state". Molecular Medicine Reports 8, no. 2 (2013): 609-612. https://doi.org/10.3892/mmr.2013.1563